What a Real Lab Report Looks Like When Everyone Online Is Selling Retatrutide
A new research compound used to stay inside university labs for years. Retatrutide skipped that stage. It went from a code name in a 2022 journal paper to a search term with hundreds of thousands of monthly lookups, and the number of websites offering it as a research chemical grew right along with the attention.
That speed creates a simple problem. When dozens of sites sell the same compound, the only thing that separates a real vial from a mislabeled one is a document most people have never been taught to read: the certificate of analysis.
Here's how to read one in about five minutes.
First, what retatrutide is and isn't
Retatrutide is an investigational peptide developed by Eli Lilly under the code LY3437943. It is not an approved medicine. What gets sold online is research-grade material intended for laboratory work. That status matters, because it means no pharmacy and no regulator stands between the buyer and the label. The certificate is the check.
The three numbers that matter
A complete certificate answers three separate questions.
The first is identity. Is the molecule in the vial actually retatrutide? Labs answer this by measuring the peptide's whole mass, usually with a technique called LC-MS, and comparing it with the mass the molecule's structure predicts. The reference figure is public in the PubChem database. A certificate that shows a measured mass close to that figure is giving you evidence. One that just says "conforms" with no number is giving you an opinion.
The second is purity, usually reported as a percentage from HPLC testing. Sellers love to advertise it. It tells you how uniform the material is, but not what the material is, so a purity figure on its own proves less than it seems.
The third is net content: how much peptide is actually in the vial compared with the amount on the label. This is the number most often missing, and it's the one that tells you whether a "10 mg" vial holds 10 mg.
When you're comparing a retatrutide peptide listing, look for all three, each with a real value.
Four warning signs
Weak certificates tend to fail in the same few ways.
The lot number on the report doesn't match the vial, or there isn't one at all.
There's a purity figure and nothing else.
The same document appears across different products or months. Real reports change dates and sample IDs.
There's no way to confirm the report with the lab that issued it.
Checking it yourself
You shouldn't need to trust the seller, and a good certificate is built so you don't have to. Match the lot number to the label. Look the report up with the issuing laboratory using the code or sample ID printed on it. Compare the measured mass with the PubChem reference. If anything doesn't line up, ask the seller to explain in writing.
Independent retesting has also become common. Sending a sealed vial to a separate lab and comparing results is the strongest check there is, and a few suppliers now put in writing what they'll do if an outside result disagrees with their certificate. Our guide to reading a retatrutide certificate of analysis walks through each line.
The short version
Transparency is easy to claim and harder to publish. The suppliers worth taking seriously print their standard before you buy: identity by mass spectrometry, a stated purity floor, a minimum net content, and certificates linked by lot. Our own release specification is on our certificates page for anyone who wants an example to compare against.
Retatrutide is an investigational compound sold for laboratory research only. It is not approved for human or veterinary use.
———
About the author: Mike Vance is Chief Research Officer at LabFirst Peptides, a US research peptide supplier in Santa Ana, California.
